Robert Flavell, MD, PhD
University of California, San Francisco
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Robert Flavell, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:28 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06894745 · PET [89Zr]DFO-starPEG in Solid TumorsRobert Flavell, MD, PhD · recruiting · Solid Tumor, Solid Carcinoma, Soft Tissue Lesion · principal investigator
- Ph1NCT05892393 · Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple MyelomaRobert Flavell, MD, PhD · recruiting · Multiple Myeloma, Plasma Cell Myeloma · principal investigator
- Early Ph1NCT05851365 · Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate CancerRobert Flavell, MD, PhD · recruiting · Prostate Cancer, Localized Prostate Carcinoma · principal investigator
- Ph1NCT05245006 · PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate CancerRobert Flavell, MD, PhD · active not recruiting · Prostate Cancer, Metastatic Castration-resistant Prostate Cancer · principal investigator
- Ph1NCT03546335 · Zr-89 Cimzia PET Imaging Rheumatoid ArthritisRobert Flavell, MD, PhD · suspended · Rheumatoid Arthritis · principal investigator
- Ph2NCT03463889 · Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid CancerUniversity of California, San Francisco · terminated · Thyroid Gland Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Molecular imaging of novel PARP inhibitor nanomedicine deliveryR01CA266666 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Rahul Aggarwal, Robert Richard Flavell, Henry F. VanBrocklin · fiscal years 2022 to 2025Named on NCT06894745
- Development of CD46 theranostics for imaging and treatment of multiple myelomaR01CA271606 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Robert Richard Flavell, Arun P. Wiita · fiscal years 2022 to 2026Named on NCT05892393
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.